https://www.selleckchem.com/pr....oducts/phosphoramido
3% on MVUS (p0.001). Comparing the extent and margins of the lesions, MVUS had better results than CDUS in 41.5% of the lesions, CDUS had better results in 6.5% and they were equal in 52% (p0.001). The diagnostic con-fidence of the APN lesions was higher for MVUS than CDUS in 36.6%, higher for CDUS than MVUS in 4.9%, and equal in the remaining 58.5% (p0.05). The interobserver agreement was fair to moderate. MVUS showed improved detectability of hypoperfused areas in paediatric APN and provided higher dia